Results 151 to 160 of about 14,249 (201)
Molecular Mechanisms of Drug Resistance in <i>Leishmania</i> spp. [PDF]
Moncada-Diaz MJ+5 more
europepmc +1 more source
Carmaphycin B-Based Proteasome Inhibitors to Treat Human African Trypanosomiasis: Structure-Activity Relationship and <i>In Vivo</i> Efficacy. [PDF]
Liu LJ+14 more
europepmc +1 more source
Efflux pumps: gatekeepers of antibiotic resistance in Staphylococcus aureus biofilms. [PDF]
Sinha S, Aggarwal S, Singh DV.
europepmc +1 more source
Importance of etiologies of secondary diabetes: How often do we think off in clinical practice?
Reddy KS+3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Annals of Internal Medicine, 1983
Excerpt To the editor: The recent case of pentamidine-induced hypoglycemia reported by Sharpe (1) prompted a chart review of patients treated with pentamidine at the Toronto General Hospital during...
John K. Murdoch, Jay S. Keystone
openaire +5 more sources
Excerpt To the editor: The recent case of pentamidine-induced hypoglycemia reported by Sharpe (1) prompted a chart review of patients treated with pentamidine at the Toronto General Hospital during...
John K. Murdoch, Jay S. Keystone
openaire +5 more sources
Clinical Infectious Diseases, 1985
Pentamidine, recently released for clinical use, is effective in therapy for the hemolymphatic stage of Gambian trypanosomiasis, antimony-resistant leishmaniasis, and Pneumocystis carinii pneumonia. The mechanism of action is unclear and may differ for different organisms.
Michael Sands+2 more
openaire +3 more sources
Pentamidine, recently released for clinical use, is effective in therapy for the hemolymphatic stage of Gambian trypanosomiasis, antimony-resistant leishmaniasis, and Pneumocystis carinii pneumonia. The mechanism of action is unclear and may differ for different organisms.
Michael Sands+2 more
openaire +3 more sources